ABT’s acquisition of an Indian drug company today (for what seemed on a cursory inspection to be a steep price) is a textbook play on The Global Demographic Tailwind. Here are some references:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.